Literature DB >> 17393107

Role of connective tissue growth factor in extracellular matrix degradation in renal tubular epithelial cells.

Chun Zhang1, Zhonghua Zhu, Jianshe Liu, Xiao Yang, Ling Fu, Anguo Deng.   

Abstract

In order to investigate the effects of connective tissue growth factor (CTGF) antisense oligodeoxynucleotide (ODN) on plasminogen activator inhibitor-1 (PAI-1) expression in renal tubular cells induced by transforming growth factor beta1 (TGF-beta1) and to explore the role of CTGF in the degradation of renal extracellular matrix (ECM), a human proximal tubular epithelial cell line (HKC) was cultured in vitro. Cationic lipid-mediated CTGF antisense ODN was transfected into HKC. After HKC were stimulated with TGF-beta1 (5 microg/L), the mRNA level of PAI-1 was detected by RT-PCR. Intracellular PAI-1 protein synthesis was assessed by flow cytometry. The secreted PAI-1 in the media was determined by Western blot. The results showed that TGF-beta1 could induce tubular CTGF and PAI-1 mRNA expression. The PAI-1 mRNA expression induced by TGF-beta1 was significantly inhibited by CTGF antisense ODN. CTGF antisense ODN also inhibited intracellular PAI-1 protein synthesis and lowered the levels of PAI-1 protein secreted into the media. It was concluded that CTGF might play a crucial role in the degradation of excessive ECM during tubulointerstitial fibrosis, and blocking the biological effect of CTGF may be a novel way in preventing renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393107     DOI: 10.1007/s11596-007-0113-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

Review 1.  Myofibroblast: a prognostic marker and target cell in progressive renal disease.

Authors:  C Badid; M Vincent; D Fouque; M Laville; A Desmoulière
Journal:  Ren Fail       Date:  2001 May-Jul       Impact factor: 2.606

2.  Expression of connective tissue growth factor in human renal fibrosis.

Authors:  Y Ito; J Aten; R J Bende; B S Oemar; T J Rabelink; J J Weening; R Goldschmeding
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

Review 3.  Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies.

Authors:  A Heidland; K Sebekova; L Paczek; M Teschner; J Dämmrich; Z Gaciong
Journal:  Kidney Int Suppl       Date:  1997-11       Impact factor: 10.545

4.  BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells.

Authors:  Shinong Wang; Raimund Hirschberg
Journal:  Am J Physiol Renal Physiol       Date:  2003-05

5.  A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene.

Authors:  G R Grotendorst; H Okochi; N Hayashi
Journal:  Cell Growth Differ       Date:  1996-04

Review 6.  Molecular basis of renal fibrosis.

Authors:  A A Eddy
Journal:  Pediatr Nephrol       Date:  2000-12       Impact factor: 3.714

7.  Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

Authors:  S Wang; M Denichilo; C Brubaker; R Hirschberg
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

8.  Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice.

Authors:  D C Han; B B Hoffman; S W Hong; J Guo; F N Ziyadeh
Journal:  Am J Physiol Renal Physiol       Date:  2000-04

9.  Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis.

Authors:  Hideki Yokoi; Masashi Mukoyama; Akira Sugawara; Kiyoshi Mori; Tetsuya Nagae; Hisashi Makino; Takayoshi Suganami; Kensei Yahata; Yuriko Fujinaga; Issei Tanaka; Kazuwa Nakao
Journal:  Am J Physiol Renal Physiol       Date:  2002-05

10.  Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.

Authors:  D M Bradham; A Igarashi; R L Potter; G R Grotendorst
Journal:  J Cell Biol       Date:  1991-09       Impact factor: 10.539

  10 in total
  2 in total

1.  CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells.

Authors:  Xiaoyu Wang; Susan V McLennan; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2011-06-02       Impact factor: 5.782

2.  A stable explant culture of HER2/neu invasive carcinoma supported by alpha-Smooth Muscle Actin expressing stromal cells to evaluate therapeutic agents.

Authors:  Marie P Piechocki
Journal:  BMC Cancer       Date:  2008-04-24       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.